key: cord-1032530-834fvb2k
authors: Temiz, Selami Aykut; Kutlu, Ömer
title: The development of dermatologic diseases in patients recovered from COVID‐19
date: 2021-02-04
journal: Dermatol Ther
DOI: 10.1111/dth.14791
sha: f2ba5667346a1189414d0d4d4ee52cbc8734a07b
doc_id: 1032530
cord_uid: 834fvb2k

nan

will be remembered as a pandemic that has brought serious destruction in human history. This disease, which progresses with severe lung involvement and failure, can be transmitted through droplets as well as body fluids containing aerosols. 1 COVID-19 is an autoinflammatory and autoimmune process that develops as a result of immune system dysfunction along with viral infection. 6 As time passes, data that shows autoimmunity develops more in COVID-19 patients is getting stronger. 6, 7 Previous cases that reported developing urticaria and alopecia areata after COVID-19 can be considered in this regard. 8, 9 Given our cases, we believe that autoimmune and autoinflammatory skin diseases such as urticaria and 

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Cutaneous signs in COVID-19 patients: a review

COVID-19 with dermatologic manifestations and implications: an unfolding conundrum

The clinics of HHV-6 infection in COVID-19 pandemic: pityriasis rosea and Kawasaki disease

Relative changes in the pattern of diseases presenting in dermatology outpatient clinic in the era of the COVID-19 pandemic

COVID-19: infection or autoimmunity

Covid-19 and autoimmunity

Urticaria in a patient with COVID-19: therapeutic and diagnostic difficulties

Short-term stress-related increasing cases of alopecia areata during the COVID-19 pandemic

Evaluation of the effects of COVID-19 pandemic on hair diseases through a web-based questionnaire